It’s very easy to go about your day-to-day life without thinking about the impact the...
Designed and manufactured by Origin Pharma Packaging, the new PP28 child-resistant closure (CRC) has been designed, engineered, and strategically optimised to become one of the lightest of its kind.
Key features of the PP28 include:
- Child-resistant design
- Specific enhanced senior-friendly design
- Bulk packing
- Increasing sustainability (reduction in polymer)
- Cleanroom production
- Approved to ISO8317
- Approved to 16CFR1700.20
- Bespoke measuring beaker
- Branding and interchangeable tool set
- Accepts all types of required liner
The PP28 CRC is designed, engineered and strategically optimised to be the lightest of their kind. These CRC closures boast the lowest possible polymer content, while retaining a robust and effective first line of defence against child access.
The new closure drives sustainability. Depending on your particular specification Origin Pharma Packaging can reduce your current waste obligation by up to 50% using bulk production methods.
The CRC can be produced in either food-grade or European and US pharmacopeia polymers, as well as can be manufactured in cleanroom environments to meet your specific production protocol.
The closure has unrivalled scope for brand promotion which is essential in today’s competitive market. It can be produced in virtually any colour at relatively small production quantities and the crown of the closure is also customisable by means of an interchangeable tool insert, providing an embossed design of your choice.
A range of clip-in liners and attachments are also available for this new device and over-printing of the embossing is optional.
Approved to ISO8317 and 16CFR1700.20 this product presents a refreshing solution to child safe compliance wherever you are in the world. Origin has considered the supply chain too, and the device can be supplied in engineered packaging designed to reduce waste.
Origin is continually redefining its closures with its dedicated new product development (NPD) department. Origin can support you in developing the optimum designs for high performance of delivery.
The US Food and Drug Administration (FDA) has granted Origin a licence to export registered...
GSK, Bristol-Myers Squibb, Novartis and AstraZeneca to name but a few are investing billions of...
As legislation and ethical awareness evolves, Origin Pharma Packaging has seen the demand for innovative...